etoposide has been researched along with ATLL in 81 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (3.70) | 18.7374 |
| 1990's | 25 (30.86) | 18.2507 |
| 2000's | 25 (30.86) | 29.6817 |
| 2010's | 21 (25.93) | 24.3611 |
| 2020's | 7 (8.64) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, Z; Li, Z; Liang, A; Tian, X; Yang, M; Yu, W; Zhang, W; Zhou, J | 1 |
| Arbelbide, J; Barcan, L; Basquiera, AL; Cristaldo, N; García-Rivello, H; Otero, V; Valledor, A; Warley, F | 1 |
| Farina, K; Kalac, M; Kim, S | 1 |
| Abe, K; Hayashi, S; Jo, T; Kaneko, Y; Kubota-Koketsu, R; Matsuo, M; Matsuzaka, K; Sakai, T; Shigematsu, K; Shioya, H; Taguchi, J; Tominaga, H | 1 |
| Cook, LB; Phillips, AA | 1 |
| Chen, CK; Hayashi, S; Ikari, K; Kusano, J; Ogai, A; Ozawa, Y; Yamamoto, R; Yoshida, R | 1 |
| Jiang, Q; Lei, CS; Qiu, L; Yu, Q | 1 |
| Iida, S; Inagaki, H; Ishida, T; Ito, A; Iwasaki, H; Kusumoto, S; Masaki, A; Murase, T; Muto, R; Nakano, N; Sakamoto, Y; Takeshita, M; Tashiro, Y; Tokunaga, M; Ueda, R; Utsunomiya, A; Yonekura, K | 1 |
| Kamachi, K; Miyahara, M; Ureshino, H | 1 |
| Fuji, S; Ohno, N; Shimada, N; Suzuki, Y; Tanosaki, R; Tojo, A; Uchimaru, K; Yuji, K | 1 |
| Horwitz, SM; Mehta-Shah, N; Ratner, L | 1 |
| Ando, K; Fukushima, T; Hata, T; Imaizumi, Y; Itonaga, H; Miyazaki, Y; Nakashima, J; Sato, S; Sawayama, Y; Taguchi, J; Taniguchi, H; Toriyama, E | 1 |
| Ishigaki, T; Kobayashi, M; Kobayashi, S; Ohno, N; Sato, K; Tojo, A; Uchimaru, K; Watanabe, N; Yuji, K | 1 |
| Kato, K | 1 |
| Hanafusa, T; Hirata, Y; Iwaki, K; Nishiwaki, U; Tsuji, M; Yokote, T | 1 |
| Fukushima, T | 1 |
| Ichikawa, K; Izumi, H; Kinoshita, A; Komatsu, N; Nakamura, N; Noguchi, M; Ohta, Y; Sawada, T; Sekiguchi, Y; Shimada, A; Suga, Y; Sugimoto, K; Tomita, S; Wakabayashi, M | 1 |
| Akinaga, S; Fujiwara, H; Imada, K; Ishida, T; Ishitsuka, K; Jo, T; Miyamoto, T; Moriuchi, Y; Nosaka, K; Saburi, Y; Suzushima, H; Taira, N; Takemoto, S; Tobinai, K; Tomonaga, M; Ueda, R; Uike, N; Uozumi, K; Utsunomiya, A; Yamamoto, K; Yoshida, S | 1 |
| Fan, Z; Hu, J; Li, L; Liang, A; Yang, M; Ye, S; Yu, W; Zhang, H; Zhang, W | 1 |
| Kimura, S; Kobayashi-Watanabe, N; Sato, A; Sueoka, E; Sueoka-Aragane, N; Watanabe, T | 1 |
| Miyahara, M; Ureshino, H | 1 |
| Abel, H; Ambinder, R; Barta, SK; Baydoun, HH; Caruso, B; Cheng, X; Harding, J; Jacobson, S; Noy, A; Parekh, S; Phillips, A; Ramos, JC; Ratner, L; Rauch, D | 1 |
| Ishida, T; Ogura, M; Takahashi, T; Tsukasaki, K; Utsunomiya, A | 1 |
| Blalock, WL; Cappellini, A; Chiarini, F; Cocco, L; Falà, F; Martelli, AM; Martinelli, G; McCubrey, JA; Tafuri, A; Tazzari, PL | 1 |
| Grossman, ME; Husain, S; MacGregor-Cortelli, B; Marneros, AG; Neylon, E; Nuovo, GJ; O'Connor, OA; Patterson, M; Silvers, DN; Zain, JM | 1 |
| Fujigaki, H; Hoshi, M; Ito, H; Ohtaki, H; Ohyama, M; Saito, K; Seishima, M; Takahashi, T; Takemura, M; Tanaka, R; Tomita, E | 1 |
| Grubb, B; Henderson, DB; Pandya, AG | 1 |
| Tsukasaki, K | 1 |
| Biémont-Trescol, MC; Bonnefoy, N; Debaud, AL; Duc Dodon, M; Gazzolo, L; Hermine, O; Macaire, H; Mahieux, R; Mesnard, JM; Moncollin, V; Pierre, M; Riquet, A; Valentin, H | 1 |
| Shirakashi, Y; Sugiura, M; Terada, T | 1 |
| Fueki-Yoshioka, H; Hama-Yamamoto, K; Hino, R; Hiromasa, K; Izu, K; Kabashima-Kubo, R; Kobayashi, M; Nakamura, M; Ohmori, S; Okura, R; Sawada, Y; Shimauchi, T; Sugita, K; Tajiri, M; Tokura, Y; Yamada, S; Yamaguchi, T; Yoshiki, R; Yoshioka, M; Yoshizawa, M | 1 |
| Connolly, DL; Davis, RC; Hamaad, A | 1 |
| Besson, C; Brebion, A; Delaunay, C; Gonin, C; Hermine, O; Panelatti, G; Plumelle, Y | 1 |
| Fukuhara, S; Ishii, K; Nomura, S; Yamamoto, Y | 1 |
| Danilatou, V; Kalmanti, M; Mantadakis, E; Papadhimitriou, S; Paterakis, G; Stiakaki, E | 1 |
| Bader, P; Boppana, S; Dormann, S; Fisch, P; Goebel, H; Jung, A; Kontny, U; Niemeyer, C; Peters, A; Strahm, B; Werner, M | 1 |
| Goumakou, H; Kotsis, K; Pagalou, E; Polyzos, A; Sfikakis, P; Tiniakoy, M; Tzianoumis, L; Xefteri, E | 1 |
| Escherich, G; Hassenpflug, WA; Horstmann, MA; Janka, G; Kabisch, H; zur Stadt, U | 1 |
| Yamada, Y | 1 |
| Hasegawa, H; Miyagi, T; Nagasaki, A; Nakachi, S; Shinzato, O; Taira, N; Takasu, N; Tomoyose, T | 1 |
| Chang, PY; Draheim, K; Kelliher, MA; Miyamoto, S | 1 |
| Fukuda, H; Fukushima, T; Hanada, S; Hotta, T; Ikeda, S; Kawano, F; Masuda, M; Momita, S; Nagoshi, H; Sano, M; Shibata, T; Shimoyama, M; Takatsuka, Y; Tamura, K; Tobinai, K; Tomonaga, M; Tsukasaki, K; Ueda, R; Utsunomiya, A; Yamaguchi, K | 1 |
| Chan, PK; Chiu, LC; Leung, KT; Li, KK; Ooi, VE; Sun, SS | 1 |
| Anastasi, J; Hayashi, Y; McGavran, L; Nucifora, G; Roulston, D; Rowley, JD; Rudinsky, R; Tsuchida, M; Zeleznik-Le, N | 1 |
| Elvin, P; Hickman, JA; Wood, AC | 1 |
| Hong, SI; Jang, JJ; Kang, YK; Kim, CW; Lee, DS; Lee, SS | 1 |
| Bolaños, F; Candelaria, M; Hurtado, R; Labardini, JR; Majluf, A; Vargas, F | 1 |
| Ezoe, A; Hirayama, Y; Kohda, K; Matsumoto, S; Matsunaga, T; Muramatsu, H; Nakazawa, O; Nobuoka, A; Takahashi, H; Watanabe, N | 1 |
| Horinouchi, M; Ishikawa, T; Komura, K; Kubuki, Y; Maeda, K; Matsuoka, H; Suzuki, M; Toyama, T; Tsubouchi, H; Uno, H | 1 |
| Hasuike, T; Hirai, M; Hirai, N; Nakao, Y; Ohta, K; Shindo, K; Takekawa, K; Tanaka, K; Yamane, T; Yasui, Y | 1 |
| Araki, K; Arima, N; Chiyoda, S; Hosokawa, T; Ikeda, S; Kawano, F; Kikuchi, H; Kinoshita, KI; Kohno, H; Matsuzaki, H; Miyoshi, I; Momita, S; Nishimura, H; Taguchi, H; Takahashi, H; Takatsuki, K; Tamura, K; Tomonaga, M; Tsuda, H; Uozumi, K; Yamada, O | 1 |
| Borg, A; Johnson, PR; Morris, D; Saunders, M; Tosswill, J; Yin, JA | 1 |
| Taguchi, H | 1 |
| Allione, A; Bernabei, P; Forni, G; Novelli, F; Rigamonti, L | 1 |
| Basi, GS; Earnshaw, WC; Eischen, CM; Kaufmann, SH; Kottke, TJ; Leibson, PJ; Martins, LM; Tung, JS | 1 |
| Etoh, K; Matsuoka, M; Suzushima, H; Takatsuki, K; Tamiya, S | 1 |
| Asai, O; Dobashi, N; Kato, A; Katori, M; Kobayashi, T; Kuraishi, Y; Nagamine, M; Tajima, N; Usui, N; Watanabe, H; Yamazaki, H; Yano, S | 1 |
| Hayashi, T; Kugimiya, T; Miyahara, Y; Takagi, M | 1 |
| Cretney, E; Johnstone, RW; Smyth, MJ | 1 |
| Akashi, T; Fukutomi, M; Funakoshi, A; Iguchi, H; Kuniyoshi, M; Ohnishi, Y; Wakasugi, H; Yokota, M | 1 |
| Ohnishi, K | 1 |
| Asano, S; Matsuoka, M; Ohata, J; Tani, K; Tojo, A; Yamashita, T | 1 |
| Bantel, H; Engels, IH; Schulze-Osthoff, K; Voelter, W; Wesselborg, S | 1 |
| Allen, PD; Kelsey, SM; Newland, AC; Richardson, DS | 2 |
| Arima, N; Fujiwara, H; Hidaka, S; Imamura, N; Kukita, T; Matsumoto, M; Matsumoto, T; Matsushita, K; Ohtsubo, H; Tei, C | 1 |
| Hayakawa, A; Kosaka, Y; Nakamura, H; Piao, JH; Sano, K | 1 |
| Akutsu, M; Bai, L; Furukawa, Y; Ichikawa, A; Kano, Y; Kon, K; Suzuki, K; Tsunoda, S | 1 |
| Bash, R; Hosler, GA; Scheuermann, RH | 1 |
| Sleiman, RJ; Stewart, BW | 1 |
| Albertioni, F; Chandra, J; Eriksson, S; Knaust, E; Liliemark, E; Lotfi, K; Månsson, E; Spasokoukotskaja, T; Wang, Y; Xu, D | 1 |
| Araki, K; Fukuda, H; Hanada, S; Hotta, T; Ikeda, S; Kawano, F; Kozuru, M; Niimi, M; Sano, M; Shimoyama, M; Takatsuki, K; Tara, M; Tobinai, K; Tomonaga, M; Utsunomiya, A; Yamada, Y | 1 |
| Amitani, S; Furusyo, H; Matano, S; Sugimoto, T; Terahata, S; Xinjia, F; Yamamoto, M | 1 |
| Haran, M; Klepfish, A; Lurie, Y; Malnick, S; Shtalrid, M | 1 |
| Hara, T; Kanemura, N; Moriwaki, H; Naito, T; Sawada, M; Tsurumi, H; Yamada, T | 1 |
| Fukuda, N; Muraki, K; Ota, I; Shimohakamada, Y; Shinohara, K | 1 |
| Akasaki, Y; Arima, N; Arimura, K; Eizuru, Y; Fujiwara, H; Hidaka, S; Kukita, T; Matsumoto, T; Matsushita, K; Ohtsubo, H; Ozaki, A; Suruga, Y; Tei, C; Wakamatsu, S | 1 |
| Arya, R; Brito-Babapulle, F; Griffiths, T; Mufti, GJ; Pagliuca, A | 1 |
| Horiuti, A; Kakishita, E; Kanamaru, A; Masaoka, T; Miyazaki, E; Nagai, K; Shibata, H; Takemoto, Y; Tsubaki, K; Yonezawa, T | 1 |
| Helbig, W; Hofmann, U; Schulze, E; Woetzel, M | 1 |
| Hiura, K; Huq, MA; Kawano, Y; Koyama, T; Kuroda, Y; Ninomiya, T; Satoh, J; Takaue, Y; Ueda, T; Watanabe, T | 1 |
9 review(s) available for etoposide and ATLL
| Article | Year |
|---|---|
Adult T-Cell Leukemia/Lymphoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leukemia-Lymphoma, Adult T-Cell; Prednisone; Vincristine; Vindesine | 2017 |
[Malignant lymphoma and adult T-cell leukemia-lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Genetic Markers; Genetic Testing; Hodgkin Disease; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Non-Hodgkin; Methylprednisolone; Positron-Emission Tomography; Prednisone; Vincristine | 2014 |
[Treatment of adult T-cell leukemia-lymphoma].
Topics: Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Methotrexate; Nitrosourea Compounds; Prednisolone; Prednisone; Prognosis; Salvage Therapy; Vincristine; Vindesine; Zidovudine | 2014 |
[Progress of the ATLL study: an overview].
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Cyclin-Dependent Kinase Inhibitor p16; Cyclophosphamide; Doxorubicin; Etoposide; Genes, p16; Genes, p53; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemic Infiltration; Mutation; Nitrosourea Compounds; Prednisolone; Receptors, Cytokine; Vincristine; Vindesine | 2005 |
Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): a report of two cases.
Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cell Lineage; Child; Child, Preschool; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Cytarabine; Enzyme Inhibitors; Etoposide; Fatal Outcome; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Mitoxantrone; Neoplasms, Second Primary; Oncogenes; Topoisomerase II Inhibitors; Translocation, Genetic | 1995 |
rHuGM-CSF after high-dose chemotherapy in post-remission acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins | 1995 |
[A case of adult T cell leukemia (lymphoma type) involving the pancreas].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Etoposide; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Pancreatic Neoplasms; Prednisolone; Remission Induction; Vincristine | 1999 |
[Oral antitumor drugs for hematological malignancies].
Topics: Administration, Oral; Antineoplastic Agents; Cytarabine; Etoposide; Hematologic Neoplasms; Humans; Hydroxyurea; Leukemia-Lymphoma, Adult T-Cell; Piperazines; Prodrugs; Tretinoin | 1999 |
Therapy-related myelodysplastic syndrome in a case of cutaneous adult T-cell lymphoma.
Topics: Acute Disease; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Japan; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Lymphoma, T-Cell, Cutaneous; Male; Nitrosourea Compounds; Prednisolone; Proviruses; Radiotherapy; Remission Induction; Translocation, Genetic; Vincristine | 2002 |
7 trial(s) available for etoposide and ATLL
| Article | Year |
|---|---|
Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Nitrosourea Compounds; Prednisolone; Treatment Outcome; Vincristine; Vindesine | 2015 |
VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Survival Rate; Vincristine | 2007 |
An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Mitoxantrone; Nitrosourea Compounds; Prednisone; Vincristine; Vindesine | 1996 |
[An intensive chemotherapy of adult T-cell leukemia/lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Mitoxantrone; Nitrosourea Compounds; Prednisolone; Proportional Hazards Models; Remission Induction; Survival Rate; Vincristine; Vindesine | 1996 |
[EPOCH therapy for relapsed/refractory lymphoid malignancies].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Infusions, Intravenous; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Treatment Outcome; Vincristine | 1998 |
A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Survival Rate; Time Factors; Vincristine; Vindesine | 2001 |
[Co-operative on salvage chemotherapy with VP-16 for malignant lymphoma. Hanshin Study Group on Treatment for Hematological Disorders].
Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Hodgkin Disease; Humans; Immunoblastic Lymphadenopathy; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone | 1992 |
65 other study(ies) available for etoposide and ATLL
| Article | Year |
|---|---|
Targeting RAD51 enhances chemosensitivity of adult T‑cell leukemia‑lymphoma cells by reducing DNA double‑strand break repair.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; DNA Breaks, Double-Stranded; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Gene Knockdown Techniques; HEK293 Cells; Humans; Imatinib Mesylate; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Rad51 Recombinase; Recombinational DNA Repair; RNA, Small Interfering | 2019 |
Complete remission and proviral load negativization after allogeneic-SCT in a patient with Adult T-cell lymphoma: Case report.
Topics: Adult; Anti-Retroviral Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Prednisolone; Proviruses; Remission Induction; Transplantation, Homologous; Treatment Outcome; Vincristine; Viral Load | 2020 |
Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma.
Topics: Acute Disease; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cardiotoxicity; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Prednisone; Vincristine | 2021 |
Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia/lymphoma.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Prednisone; Prognosis; Proportional Hazards Models; Retreatment; Retrospective Studies; Treatment Outcome; Vincristine | 2020 |
How I treat adult T-cell leukemia/lymphoma.
Topics: Aged; Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prednisone; Raltegravir Potassium; Recurrence; Remission Induction; Therapies, Investigational; Vincristine; Virus Activation; Zidovudine | 2021 |
[A Case of Adult T-Cell Leukemia/Lymphoma with Severe Hand-Foot Syndrome during Administration of Modified LSG15 Regimen].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hand-Foot Syndrome; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma; Middle Aged; Nitrosourea Compounds; Prednisolone; Vincristine; Vindesine | 2020 |
Cutaneous plaque in adult T cell leukemia/lymphoma: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Flow Cytometry; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Prednisolone; Prednisone; Skin Diseases; Vincristine | 2020 |
Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD28 Antigens; Cyclophosphamide; DNA Copy Number Variations; Doxorubicin; Etoposide; Female; Genes, p53; Hematopoietic Stem Cell Transplantation; Humans; INDEL Mutation; Kaplan-Meier Estimate; Lenalidomide; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Mutation; Nitrosourea Compounds; Polymorphism, Single Nucleotide; Prednisolone; Prednisone; Prognosis; Receptors, CCR4; Vincristine; Vindesine | 2021 |
Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Prednisolone; Prognosis; T-Cell Antigen Receptor Specificity; T-Lymphocytes, Cytotoxic; Vincristine | 2017 |
Therapy-related Acute Myeloid Leukemia after the Long-term Administration of Low-dose Etoposide for Chronic-type Adult T-cell Leukemia-lymphoma: A Case Report and Literature Review.
Topics: Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid, Acute; Middle Aged; Translocation, Genetic | 2017 |
EPOCH regimen as salvage therapy for adult T-cell leukemia-lymphoma.
Topics: Adult; Aged; Allografts; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Prednisone; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine | 2018 |
Loss of CCR4 antigen expression after mogamulizumab therapy in a case of adult T-cell leukaemia-lymphoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clone Cells; Cyclophosphamide; Down-Regulation; Doxorubicin; Etoposide; Fatal Outcome; Female; Gene Expression Regulation, Neoplastic; Humans; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Neoplasm Proteins; Nitrosourea Compounds; Prednisone; Receptors, CCR4; Vincristine; Vindesine | 2013 |
Syndrome of inappropriate antidiuretic hormone secretion associated with adult T-cell leukaemia/lymphoma.
Topics: Aged; Antineoplastic Agents, Phytogenic; Etoposide; Female; Humans; Inappropriate ADH Syndrome; Leukemia-Lymphoma, Adult T-Cell; Tumor Lysis Syndrome | 2014 |
A case of post-mogamulizumab relapse of acute-type adult T-cell leukemia/lymphoma successfully treated with mogamulizumab and etoposide.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Etoposide; Humans; Immunohistochemistry; Leukemia-Lymphoma, Adult T-Cell; Male; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Remission Induction; Skin; Time Factors; Treatment Outcome; Whole Body Imaging | 2014 |
SIRT1 downregulation enhances chemosensitivity and survival of adult T-cell leukemia-lymphoma cells by reducing DNA double-strand repair.
Topics: Adult; Animals; Antigens, Nuclear; DNA Breaks, Double-Stranded; DNA Damage; DNA End-Joining Repair; DNA Repair; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Forkhead Box Protein O1; Forkhead Transcription Factors; Homologous Recombination; Humans; Jurkat Cells; Ku Autoantigen; Leukemia-Lymphoma, Adult T-Cell; Mice; Sirtuin 1; Xenograft Model Antitumor Assays | 2015 |
Torin2 Potentiates Anticancer Effects on Adult T-Cell Leukemia/Lymphoma by Inhibiting Mammalian Target of Rapamycin.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Etoposide; G1 Phase Cell Cycle Checkpoints; Humans; Leukemia-Lymphoma, Adult T-Cell; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Multiprotein Complexes; Naphthyridines; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2016 |
Spontaneous regression of adult T cell leukemia/lymphoma following development of immune thrombocytopenia.
Topics: Adrenal Cortex Hormones; Allografts; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Nitrosourea Compounds; Prednisolone; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Remission, Spontaneous; Vincristine; Vindesine | 2016 |
Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cyclophosphamide; Doxorubicin; Etoposide; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Prednisone; Raltegravir Potassium; Treatment Outcome; Vincristine | 2016 |
Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Case-Control Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Flow Cytometry; Humans; Killer Cells, Natural; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Vincristine; Vindesine | 2016 |
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-cell acute lymphoblastic leukemia.
Topics: Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Etoposide; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indazoles; Indoles; Leukemia-Lymphoma, Adult T-Cell; Phosphorylation; Phosphoserine; Phosphothreonine; Proto-Oncogene Proteins c-akt | 2008 |
Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia causing skin erosions.
Topics: Adult; Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biopsy; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Doxorubicin; Drug Eruptions; Epidermis; Etoposide; Exanthema; Folic Acid Antagonists; Humans; Interferon alpha-2; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Prednisone; Recombinant Proteins; Vincristine; Zidovudine | 2009 |
Changes in serum tryptophan catabolism as an indicator of disease activity in adult T-cell leukemia/lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Monitoring; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Leukemia-Lymphoma, Adult T-Cell; Metabolic Networks and Pathways; Neoplasm Proteins; Neoplastic Cells, Circulating; Neutropenia; Nitrosourea Compounds; Prednisone; Receptors, Interleukin-2; Tryptophan; Tryptophan Oxygenase; Vincristine; Vindesine | 2009 |
Adult T-cell lymphoma/leukemia presenting as pagetoid reticulosis of the palms and soles.
Topics: Adult; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Diagnostic Errors; Doxorubicin; Etoposide; Fatal Outcome; Foot; Hand; Humans; Interferons; Jamaica; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Pagetoid Reticulosis; Prednisone; Skin Neoplasms; Vincristine; Zidovudine | 2011 |
Adult T-cell leukemia-lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Nitrosourea Compounds; Prednisolone; Vincristine; Vindesine | 2012 |
Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T-cells.
Topics: Adult; Antineoplastic Agents, Phytogenic; Basic-Leucine Zipper Transcription Factors; bcl-X Protein; Biphenyl Compounds; CD4-Positive T-Lymphocytes; Cell Survival; DNA-Binding Proteins; Etoposide; Female; Gene Knockdown Techniques; Gene Products, tax; Genes, jun; HeLa Cells; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Ligases; Male; Minor Histocompatibility Antigens; NF-kappa B p50 Subunit; Nitrophenols; Nuclear Proteins; Piperazines; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-rel; Retroviridae Proteins; Sulfonamides; Transcription Factor RelB; Transcription, Genetic; Viral Proteins | 2012 |
T-cell lymphoma of the penis as the first manifestation of adult T-cell lymphoma/leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, T-Cell, Cutaneous; Male; Maxillary Neoplasms; Middle Aged; Penile Neoplasms; Prednisone; Treatment Outcome; Vincristine | 2012 |
Combination of skin-directed therapy and oral etoposide for smoldering adult T-cell leukemia/lymphoma with skin involvement.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Fatigue; Female; Humans; Kaplan-Meier Estimate; Leukemia-Lymphoma, Adult T-Cell; Leukopenia; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Prednisolone; Proportional Hazards Models; Retrospective Studies; Skin; Ultraviolet Therapy; Vomiting | 2013 |
Regression of HTLV1 associated intracardiac lymphoma following chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Heart Neoplasms; Humans; Ifosfamide; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Prednisone; Remission Induction; Ultrasonography; Vincristine | 2002 |
Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Prednisone; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine; Zalcitabine; Zidovudine | 2002 |
[Adult T-cell leukemia/lymphoma of bone with multiple pathological fractures].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Extremities; Fatal Outcome; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Nitrosourea Compounds; Osteolysis; Prednisolone; Vincristine; Vindesine | 2004 |
T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Antigens, CD7; Antigens, Differentiation, T-Lymphocyte; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cell Differentiation; Cell Lineage; Core Binding Factor Alpha 2 Subunit; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Female; Gene Dosage; Histone-Lysine N-Methyltransferase; Humans; Immunophenotyping; Karyotyping; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Mercaptopurine; Methotrexate; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Neoplastic Stem Cells; Proto-Oncogenes; Recurrence; T-Lymphocyte Subsets; Vincristine | 2007 |
Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Clone Cells; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Cytarabine; Daunorubicin; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Glucocorticoids; Graft vs Host Disease; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Transfusion; Lymphoproliferative Disorders; Male; Postoperative Complications; Prednisolone; Rituximab; Time Factors; Transplantation Chimera; Transplantation Conditioning; Vincristine; Virus Activation; Whole-Body Irradiation | 2005 |
VAD for remission induction as a first line and in relapsed adult acute lymphoblastic leukemia (ALL).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Recurrence; Remission Induction | 1989 |
Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.
Topics: Adolescent; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Deoxycytidine; Dexamethasone; Drug Evaluation; Drug Synergism; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Infant; Leukemia-Lymphoma, Adult T-Cell; Male; Methylprednisolone; Neoplasm, Residual; Peripheral Blood Stem Cell Transplantation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recombinant Proteins; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thiotepa; Topotecan; Treatment Outcome; Vidarabine; Vinblastine | 2005 |
[Development of acute type, CD 8 positive adult T-cell leukemia in a carrier of hepatitis B virus--possible therapeutic effect of lamivudine combined with chemotherapy].
Topics: Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carrier State; CD8-Positive T-Lymphocytes; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Hepatitis B; HTLV-I Antibodies; Humans; Irinotecan; Lamivudine; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Mitoxantrone; Nitrosourea Compounds; Pentostatin; Prednisone; Vincristine | 2006 |
NFKB1 is a direct target of the TAL1 oncoprotein in human T leukemia cells.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Cell Line, Tumor; Etoposide; Gene Expression Regulation, Leukemic; Humans; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Transgenic; NF-kappa B p50 Subunit; Promoter Regions, Genetic; Proto-Oncogene Proteins; T-Cell Acute Lymphocytic Leukemia Protein 1; Transcription Factor RelA; Transcription, Genetic | 2006 |
Activation of the JNK pathway promotes phosphorylation and degradation of BimEL--a novel mechanism of chemoresistance in T-cell acute lymphoblastic leukemia.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Blotting, Western; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Humans; Hydrolysis; Leukemia-Lymphoma, Adult T-Cell; MAP Kinase Kinase 4; Membrane Proteins; Phosphorylation; Proto-Oncogene Proteins; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
Induction of apoptosis by anti-cancer drugs with disparate modes of action: kinetics of cell death and changes in c-myc expression.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Death; Cycloheximide; Dexamethasone; Etoposide; Formamides; Gene Expression; Genes, myc; Humans; Leukemia-Lymphoma, Adult T-Cell; Tumor Cells, Cultured | 1995 |
Adult T-cell leukemia/lymphoma in a Korean--a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA, Viral; Doxorubicin; Etoposide; Human T-lymphotropic virus 1; Humans; Immunophenotyping; Korea; Leukemia-Lymphoma, Adult T-Cell; Lymph Nodes; Male; Middle Aged; Neoplastic Stem Cells; Prednisone; Proviruses; Vincristine | 1994 |
[Two cases of adult T-cell leukemia . lymphoma (ATL) with long-term remission by chronic daily administration of low-dose etoposide].
Topics: Administration, Oral; Adult; Central Nervous System Neoplasms; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Prognosis; Skin Neoplasms | 1995 |
[Successful chronic daily administration of oral etoposide for a case of adult T cell leukemia].
Topics: Administration, Oral; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Middle Aged | 1993 |
[Adult T cell leukemia/lymphoma effectively treated with chronic oral etoposide].
Topics: Administration, Oral; Drug Administration Schedule; Etoposide; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Remission Induction | 1993 |
Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Etoposide; Female; Graft Survival; Humans; Infusions, Intravenous; Leukemia-Lymphoma, Adult T-Cell; Transplantation, Homologous | 1996 |
Antiblastic chemotherapy drugs up-modulate interferon-gamma receptor expression on human malignant T cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cisplatin; Cytarabine; Daunorubicin; Etoposide; Flow Cytometry; Interferon gamma Receptor; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, T-Cell; Neoplastic Stem Cells; Receptors, Interferon; T-Lymphocytes; Tumor Cells, Cultured; Up-Regulation | 1997 |
Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions.
Topics: Affinity Labels; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Biotin; Camptothecin; Caspase 3; Caspase 7; Caspases; Cisplatin; Cysteine Endopeptidases; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Fas Ligand Protein; fas Receptor; Flow Cytometry; Humans; Lamin Type B; Lamins; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Methotrexate; Neoplasm Proteins; Nuclear Proteins; Oligopeptides; Poly(ADP-ribose) Polymerases; Staurosporine; Topoisomerase II Inhibitors; Topotecan; Tumor Cells, Cultured | 1997 |
Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells.
Topics: Adult; Aged; Alleles; Antibodies, Monoclonal; Antineoplastic Agents; Antiviral Agents; Apoptosis; Cyclophosphamide; DNA Mutational Analysis; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Exons; fas Receptor; Fatal Outcome; Gene Expression Regulation, Leukemic; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Neoplasm Proteins; Neoplastic Stem Cells; Neutrophils; Polymerase Chain Reaction; Prednisone; RNA, Messenger; RNA, Neoplasm; Sequence Deletion; T-Lymphocytes; Vincristine; Zidovudine | 1998 |
Six-year survival after excision of cardiac malignant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Etoposide; Female; Heart Neoplasms; Humans; Leukemia-Lymphoma, Adult T-Cell; Pentostatin; Prednisolone; Vincristine | 1998 |
P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caspases; Cytotoxicity, Immunologic; Dexamethasone; DNA, Complementary; Enzyme Inhibitors; Etoposide; Fas Ligand Protein; fas Receptor; Genes, MDR; Granzymes; Humans; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Neoplasm Proteins; Perforin; Pore Forming Cytotoxic Proteins; Recombinant Proteins; Serine Endopeptidases; Transfection; Tumor Necrosis Factor-alpha; Tumor Stem Cell Assay; Ultraviolet Rays; Verapamil; Vinblastine | 1999 |
CD4/CD8 double-positive adult T cell leukemia with preceding cytomegaloviral gastroenterocolitis.
Topics: Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD4 Antigens; CD8 Antigens; Cyclophosphamide; Cytomegalovirus Infections; Doxorubicin; Enterocolitis; Etoposide; Gastritis; Hepatomegaly; Human T-lymphotropic virus 1; Humans; Immunocompromised Host; Immunophenotyping; Leukemia-Lymphoma, Adult T-Cell; Male; Neoplastic Stem Cells; Nitrosourea Compounds; Prednisolone; T-Lymphocyte Subsets; Vincristine; Vindesine | 1999 |
Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis.
Topics: Amino Acid Chloromethyl Ketones; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptotic Protease-Activating Factor 1; Arabidopsis Proteins; Brefeldin A; Caspase 3; Caspase 8; Caspase 9; Caspases; Cysteine Proteinase Inhibitors; Cytochrome c Group; Drug Synergism; Enzyme Activation; Enzyme Precursors; Etoposide; fas Receptor; Fatty Acid Desaturases; Humans; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Leukemia, B-Cell; Mitochondria; Mitomycin; Neoplasm Proteins; Plant Preparations; Plant Proteins; Proteins; Ribosome Inactivating Proteins, Type 2; Toxins, Biological; Tumor Cells, Cultured | 1999 |
Inhibition of FAS/FAS-ligand does not block chemotherapy-induced apoptosis in drug sensitive and resistant cells.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Cell Cycle; Clone Cells; Drug Resistance, Multiple; Etoposide; Fas Ligand Protein; fas Receptor; HL-60 Cells; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Tumor Cells, Cultured; Vidarabine; Vinblastine | 1999 |
Effects of PARP inhibition on drug and Fas-induced apoptosis in leukaemic cells.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Drug Resistance, Multiple; Enzyme Inhibitors; Etoposide; fas Receptor; Genes, MDR; HL-60 Cells; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Microtubules; Phenanthrenes; Poly(ADP-ribose) Polymerase Inhibitors; Tumor Cells, Cultured; Vidarabine; Vinblastine | 1999 |
Long-term maintenance combination chemotherapy with OPEC/MPEC (vincristine or methotrexate, prednisolone, etoposide and cyclophosphamide) or with daily oral etoposide and prednisolone can improve survival and quality of life in adult T-cell leukemia/lymph
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Prednisolone; Quality of Life; Survival Rate | 1999 |
Novel SH3 protein encoded by the AF3p21 gene is fused to the mixed lineage leukemia protein in a therapy-related leukemia with t(3;11) (p21;q23).
Topics: Adaptor Proteins, Signal Transducing; Adolescent; Amino Acid Sequence; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; DNA, Complementary; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Monocytic, Acute; Molecular Sequence Data; Muscle Proteins; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Nitrosourea Compounds; Nuclear Proteins; Oncogene Proteins, Fusion; Sequence Alignment; Sequence Homology, Nucleic Acid; src Homology Domains | 2000 |
In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Survival; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Humans; Hydroxyurea; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Methotrexate; Neoplastic Stem Cells; Tumor Cells, Cultured; Vidarabine; Vidarabine Phosphate; Vincristine | 2000 |
Kinetics of early therapeutic response as measured by quantitative PCR predicts survival in a murine xenograft model of human T cell acute lymphoblastic leukemia.
Topics: Animals; Antineoplastic Agents; Calibration; Cell Cycle; Cyclophosphamide; Cytarabine; DNA, Neoplasm; Doxorubicin; Drug Evaluation; Etoposide; Female; Flow Cytometry; Humans; Leukemia-Lymphoma, Adult T-Cell; Methotrexate; Mice; Mice, SCID; Neoplasm Transplantation; Neoplasm, Residual; Polymerase Chain Reaction; Prognosis; Reference Standards; Risk Assessment; Specific Pathogen-Free Organisms; Survival Analysis; Transplantation, Heterologous; Tumor Cells, Cultured; Vincristine | 2000 |
Early caspase activation in leukemic cells subject to etoposide-induced G2-M arrest: evidence of commitment to apoptosis rather than mitotic cell death.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspases; Cell Death; Enzyme Activation; Etoposide; G2 Phase; Humans; Leukemia-Lymphoma, Adult T-Cell; Mitosis; Tumor Cells, Cultured | 2000 |
Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide.
Topics: 5'-Nucleotidase; Blotting, Western; Cell Line; Cladribine; Cytarabine; Deoxycytidine Kinase; Deoxycytosine Nucleotides; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Etoposide; Fas Ligand Protein; Genes, MDR; Humans; Isoenzymes; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins | 2001 |
[Low-dose etoposide in a patient with adult T-cell leukemia/lymphoma who had severe complications].
Topics: Aged; Antineoplastic Agents, Phytogenic; Aortic Aneurysm; Aortic Dissection; Cerebral Infarction; Etoposide; Female; Heart Failure; Humans; Hypertension, Pulmonary; Leukemia-Lymphoma, Adult T-Cell; Pulmonary Embolism | 2001 |
[Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Reverse Transcriptase Inhibitors; Vincristine; Virus Activation | 2001 |
Acute myeloid leukemia with t(11;19)(q23;p13) developing in an adult T-cell leukemia patient treated with combined chemotherapy including etoposide.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 19; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Middle Aged; Neoplasms, Second Primary; Translocation, Genetic | 2001 |
Interferon-alpha therapy following autologous peripheral blood stem cell transplantation for adult T cell leukemia/lymphoma.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Immunologic Factors; Interferon-alpha; Killer Cells, Natural; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Nitrosourea Compounds; Remission Induction; T-Lymphocytes, Cytotoxic; Transplantation, Autologous; Vincristine | 2002 |
BEAM regimen and G-CSF in HTLV-I-associated T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Drug Therapy, Combination; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Humans; Leukemia-Lymphoma, Adult T-Cell; Melphalan; Middle Aged | 1992 |
Growth of hemopoietic cells after incubation with VP 16-213.
Topics: Bone Marrow; Cell Division; Cell Survival; Etoposide; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid, Acute; Macrophages | 1989 |
[Rapid and complete hematopoietic reconstitution following peripheral blood stem cell autotransplantation in a child with T cell acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukocyte Count; Nitrosourea Compounds; Platelet Count; Transplantation, Autologous | 1989 |